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Faculty of Medicine Ramathibodi Hospital, Mahidol University,
angkok, Thailand
Background: Cardiovascular disease has become important
ause of death among HIV-infected patients. The risk of acute
yocardial infarction (AMI) inHIV-infected Thai patients has never
een evaluated. This study aimed to evaluate the risk of AMI using
AMA-EGAT score among HIV-infected patients in Ramathibodi
ospital.
Methods: A cross-sectional study was carried out in HIV-
nfected patients who visited Infectious Disease Clinic at Ramath-
bodi Hospital, Mahidol University, Bangkok, Thailand between
ugust and December 2011. The risk of AMI was determined using
AMA-EGAT risk in all patients. Patients were categorized into two
roups according to the score: high risk (RAMA-EGAT score≥6) and
ow risk (RAMA-EGAT score <6).
Results: A total of 109 HIV-infected patients were studied. The
ean age was 47.3 years old and 67% of patients were male.
ean duration of HIV infection was 8.5 years. Mean CD4 cell count
as 485 cell/mm3. Twenty (18%) patients had hypertension and
se antihypertensive drugs; 14 (13%) patients had diabetes melli-
us. Almost all patients (99.1%) had received antiretroviral therapy
ART). Twenty (18%) patients had lipodystrophy as adverse drug
ffect. Mean body weight and body mass index (BMI) were 61.2 kg
nd 22.5 kg/M2, respectively. Of all, 12 (11%) patients had high
isk. When patients were categorized into high and risk group,
atients with high risk had older age (65.1vs45.6 years, p<0.001),
igher waist circumference (87.2vs80.2 cm, p=0.006), higher sys-
olic blood pressure (144vs130mmHg, p=0.008). Hypertension
67%vs12%, p<0.001) and diabetes (58%vs7%, p<0.001) are also
ore common in high risk group. HDL had a trend toward lower in
igh risk group (40.3vs48.1mg/dL, p=0.075). In multivariate anal-
sis, age [OR (per 5 yrs increased) 8.6; p=0.005], diabetes [OR 63.1;
= 0.020] and HDL [OR (per 5mg/dl increased) 0.2, p=0.020] were
actors signiﬁcantly associated with high EGAT risk score.
Conclusion: Using RAMA-EGAT score, 11% of HIV-infected
atients have high risk for AMI. Older age, presence of diabetes
nd low HDL level signiﬁcantly predict the high risk for AMI.
arly screening for diabetes and HDL level, as well as appropriate
lycemic control and regular exercise intervention are crucial for
reventing AMI in HIV-infected patients receiving ART in Thailand.
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Antiretroviral drug resistance among treatment-naïve HIV-1
patients in southern Taiwan
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Background: Antiretroviral drug resistance can reduce the
effectiveness of HIV-1 therapy. Resistance should be examined
among the treatment-naïve HIV-1 infected so that optimal drugs
therapy can be prescribed. We studied its prevalence and pattern
among 101 newly identiﬁed HIV-1 patients in southern Taiwan.
Methods: HIV-1 RNA from plasma was sequenced for the pro-
tease (PR) and reverse transcriptase region, from which the HIV-1
subtype can also be determined. Drug-resistant mutations were
examined using the algorithm of the French National Agency for
AIDS Research (ANRS).
Results: Subtypes were 43 B’, 8 CRF01 AE and 50 CRF07 BC.
Averages of two clinical parameters were calculated for each sub-
type: CD4 counts and HIV copies (in log10) were both the worse
among patients with the CRF01 AE and the best in patients with
theCRF07 BC (all p <0.05, t-test). Resistance to3 categories of drugs
was examined: Nucleoside Reverse Transcriptase Inhibitor (NRTI),
non-Nucleoside Reverse Transcriptase Inhibitor (NNRTI) and Pro-
tease Inhibitor (PI); ﬁve and nine patients harbored mutations that
conferred resistance and possible resistance to at least one drug,
respectively. Among the 3 subtypes, B’ had the highest resistance
to any drug, 6.4%, followed by CRF07 BC, 4%. When analyzed by 3
drug categories: 1 patient was resistant and 2 were possible resis-
tant to any NRTI; 4 were resistant and 1 was possible resistant to
any NNRTI; 1 was resistant and 7 was possible resistant to any
PI. When further stratiﬁed by subtypes: 2% CRF07 BC was resis-
tant and 4.7% B’ were possible resistant to any NRTI; 4.7% B’ and
4% CRF07 BC were resistant, as well as 2.3% B’ was possible resis-
tant to any NNRTI; 2.3% B’ was resistant, as well as 4.7% B’, 50%
CRF01 AE and 2% CRF07 BC were possible resistant to any PI. The
50% “possible resistance” to PI drugs for CRF01 AE was unusually
high. Because resistance-mutation deﬁnitions in ANRS, including
secondary mutations, were mostly based on B subtype, the PR gene
of the CRF01 AE could contain polymorphic substitutions thatwere
mis-interpreted as mutations.
Conclusion: Among HIV-1 treatment-naïve patients in south-
ern Taiwan, B’ subtype and NNRTIs were associated with higher
percentages of drug resistance as compared to other groups. Fur-
ther in-vitro studies on the PR gene of the CRF01 AE are warranted
to clarify roles of the known secondary mutations in this subtype.
http://dx.doi.org/10.1016/j.ijid.2012.05.762
